
In today’s ACT Brief, we examine what drives inconsistent oncology trial screening, why FDA has reportedly paused its priority voucher pilot, and how patients’ use of AI is reshaping how sponsors communicate with them.
Click the title above to open the Applied Clinical Trials March 2020 issue in an interactive PDF format.
.
over 6 years ago
Investing in Data Science to Unlock Clinical Data Valueover 6 years ago
Clinical Data Manager: A Roadmap for the Futureover 6 years ago
The Importance of Site Selectionover 6 years ago
Three Key Takeaways from SCOPEover 6 years ago
Scalability: Solving the Unique Clinical Trial Data Problemover 6 years ago
Oncology Therapies Poised for Further Gains at FDAover 6 years ago
EU Specialists: Ease the Age Barrier for Cancer Clinical Trialsover 6 years ago
News Notesover 6 years ago
Untapped Opportunity to Improve the Vendor Qualification Process





